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# 1509/QUALITY OF LIFE OF ALLERGIC RHINITIS PATIENTS WITH
IMMUNOTHERAPY
Po-Jen Liu, Otolaryngology, Cheng-Ching Hospital, Taichung, Taiwan
ROC; Tsai-Chung Li, Chinese Medicine, China Medical University,
Taichung, Taiwan, ROC
Aims: Allergic rhinitis is one of the common disorders in Taiwan. The
treatments of allergic rhinitis include aggressive environmental control,
medicine, surgery and immunotherapy. The effect of immunotherapy
on quality of life (QOL) for patients with allergic rhinitis has never been
explored, so the objective of the current study is to examine how QOL
in allergic rhinitis patients with immunotherapy is different from allergic
rhinitis patients without treatment and normal individuals. Methods: A
cross-sectional study design with three groups was conducted.
Twenty-nine patients with allergic rhinitis without treatment (group
AR), 26 patients with immunotherapy (group ARIT), and 30 persons
without allergic rhinitis (group normal) were recruited in a teaching
hospital. The generic outcome measure is Short Form 36 (SF-36) and
disease-specific outcome measure is Allergic Rhinitis Quality of Life
Instrument (ARQOL). ARQOL consists of three domains: symptoms,
activity restriction, and medical resource utilization. Results: The
findings indicate that group AR has worse QOL than Taiwan norms on
all SF-36 scales except for physical functioning and bodily pain (all
p < 0.05) while group ARIT has worse QOL only on general health
comparing to Taiwan norms (p < 0.05). For ARQOL, group normal has
higher scores for all subscales and total scale than groups AR and
ARIT (p < 0.05). In addition, the scores of group ARIT are significantly
higher than those of group AR for all subscales and total scale of
ARQOL except for medical resource utilization. Conclusions: In gen-
eral, allergic rhinitis has great impact on generic QOL but generic QOL
approaches the same level after immunotherapy. Although immuno-
therapy improves disease-specific QOL of allergic rhinitis patients,
there still exist differences between patients with immunotherapy and
normal persons.
# 1518/RELATIONSHIPS BETWEEN URINARY INCONTINENCE,
HEALTH STATUS AND SOCIAL SUPPORT PERCEPTION
Jose Pais-Ribeiro & A. Raimundo, Psychology, University of Porto,
Porto, Portugal
Aims: The aim of the present study is to identify the relationships
between perception of social support, health status and distress due to
urinary incontinence and other UI disease variables. Methods: Par-
ticipants include 93 women suffering from UI, with a mean age of 60,15
years, (varying between 35 and 81 years of age) 74.2% married. A co
relational study compare social support Instruments used include the
Portuguese version of the health status Questionnaire SF-8 with two
components, Mental Health (Cronbach a = 0.81) and physical health
(Cronbach a = 0.84); social support perception (SSP) with four
dimensions (satisfaction with friends, satisfaction with intimacy, satis-
faction with family, satisfaction with social activities); Urogenital Dis-
tress Inventory Questionnaire with six items (UDI-6) evaluating the
level of distress due to UI (Cronbach a = 0.73); Other disease vari-
ables include duration of disease (DD) and perception of level of UI
severity (UIS )(four levels- no, slight, severe, and very severe). Re-
sults: Results show statistically significant correlations between UDI-6
and health status (r = )0.25, p < 0.05 with mental component and
r = )0.20, p < 0.05 with physical component). No statistically signifi-
cant correlations were found between Health Status and UIS or DD.
Statistically significant correlations were found between dimensions of
SSP and DD (r = 0.21 p < 0.05 for satisfaction with friends, and
r = 0.23 p < 0.05 satisfaction with intimacy). No statistically significant
correlations were found between SSP and UDI-6, or UIS; No statisti-
cally significant correlations were found between health status and UIS
or DD. Conclusions: An overall assessment of results suggests that
various aspects of UI have different impacts on domains of life such as
health status and social support with the women showing adjustment
to their disease status when the DD grows, and a decreasing Health
Status with increasing UDI-6 severity.
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Russia
Aims: The goal of treatment of chronic diseases that do not shorten life
expectancy is to improve patients QoL. Evaluation of QoL along with
clinical response might be recommended for patient management.
The aim of the study was to develop QoL response paradigm in clinical
practice and demonstrate its application on the model of RA. Methods:
200 patients with RA in active phase were enrolled. Patients filled in
SF-36 at baseline and in 8 weeks of treatment. According to the par-
adigm there are 3 types of QoL response: complete response (CR),
partial response (PR) and no response (NR). CR is correspondence of
QoL after treatment to population norm; PR – improvement of QoL
after treatment but not attaining CR; NR – absence of PR. To assess
QoL response the integral QoL index (IQLI) was calculated by integral
profiles method. To evaluate CR the lower bound of population norm
mean was determined by bootstrap method (Confidence level – 0.99).
Significance of differences between groups was tested by Mann–
Whitney or Wilcoxon tests. Results: In 8 weeks 14 patients (7%) had
CR, 126 (63%)-PR and 60 (30%)-NR. In patients with CR significant
increase of SF-36 scales and IQLI as compared with base-line
(p < 0.01) was shown. The values of IQLI in this subgroup achieved
the lower bound of population norm mean and did not differ from the
ones of population sample (p = 0.63). The values of IQLI in patients
with PR improved after treatment (p < 0.01) but were lower than of
population norm. Inpatients with NR worsening of IQLI after treatment
was observed as compared with base-line. Conclusions: QoL re-
sponse paradigm in clinical practice is developed. Its application to RA
allowed to demonstrate the following stratification of QoL response:
7%of patients had CR; 63%-PR and 30%-NR. The further studies on
the other models of chronic disorders and comparison of QoL and
clinical response are worthwhile.
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